InvestWiser
Monsenso AS
MONSO · Nasdaq Copenhagen · Healthcare
0.25DKK
0.0%last day
Price as of 2 October 2026
Performance
1 month
−14.4%
1 year
+1.6%
3 years, per year
−18.2%
5 years, per year
−48.0%
Largest fall, 3 years
−98.5%
Below the peak now
−98.7%
Volatility, 1 year
200.5%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
3.5
Dividend yield
0.0%
Return on equity
−100.9%
Net margin
−95.7%
Market value
4 m USD
Quality, value and trend
Where Monsenso stands against every Nordic stock today. 100 is best.
49
Profitability and a sound balance sheet over time. Better than 49% of Nordic stocks.
12
The price measured against earnings, assets and cash flow. Better than 12% of Nordic stocks.
61
The price development over the past year. Better than 61% of Nordic stocks.
30
Quality, value and trend together. Better than 30% of Nordic stocks.
About Monsenso
Monsenso AS is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 9 employees.
Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis